1. Home
  2. IMMR vs CRBU Comparison

IMMR vs CRBU Comparison

Compare IMMR & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$6.44

Market Cap

229.4M

Sector

Technology

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.67

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMR
CRBU
Founded
1993
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.4M
203.9M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
IMMR
CRBU
Price
$6.44
$1.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$12.25
$9.33
AVG Volume (30 Days)
689.7K
997.8K
Earning Date
12-19-2025
11-12-2025
Dividend Yield
4.65%
N/A
EPS Growth
57.07
N/A
EPS
2.04
N/A
Revenue
$163,133,000.00
$9,295,000.00
Revenue This Year
$988.71
N/A
Revenue Next Year
$109.72
$4.96
P/E Ratio
$3.16
N/A
Revenue Growth
338.21
N/A
52 Week Low
$5.65
$0.66
52 Week High
$9.37
$3.54

Technical Indicators

Market Signals
Indicator
IMMR
CRBU
Relative Strength Index (RSI) 42.03 36.53
Support Level $6.42 $1.82
Resistance Level $7.09 $1.75
Average True Range (ATR) 0.19 0.10
MACD -0.04 -0.01
Stochastic Oscillator 6.16 14.49

Price Performance

Historical Comparison
IMMR
CRBU

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: